Incidence, pattern and clinical relevance of microbial contamination of preservation fluid in liver transplantation

Annals of Transplantation

Volumn 17, Issue 3, 2012, Pages 20-28

  Grat, Michał ^a   Ligocka, Joanna ^a   Lewandowski, Zbigniew ^a   Barski, Krzysztof ^a   Hołówko, Wacław ^a   Skalski, Michał ^a   Kornasiewicz, Oskar ^a   Usarek, Paulina ^a   Zieniewicz, Krzysztof ^a   Młynarczyk, Grazyna ^a   Krawczyk, Marek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Bacterial infections; Organ preservation solutions; Transplant recipient

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; PIPERACILLIN PLUS TAZOBACTAM; PRESERVATION FLUID; PRESERVATION SOLUTION; UNCLASSIFIED DRUG;

ARTICLE; BACTEREMIA; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BILIRUBIN BLOOD LEVEL; BLOODSTREAM INFECTION; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; GRAM POSITIVE BACTERIUM; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MICROBIAL CONTAMINATION; POSTOPERATIVE PERIOD; RETRANSPLANTATION;

EID: 84868694938     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/aot.883454     Document Type: Article

References (24)

1. Kaido T, Egawa H, Tsuji H et al: In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive cases at a single center. Liver Transpl, 2009; 15: 1420-25
2. Xu L, Xu MQ, Yan LN et al: Causes of mortality after liver transplantation: a single center experience in mainland china. Hepatogastroenterology, 2012; 59: 481-84
3. Kim YJ, Kim SI, Wie SH et al: Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience. Transpl Infect Dis, 2008; 10: 316-24
4. Chow JK, Werner BG, Ruthazer R, Snydman DR: Increased serum iron levels and infectious complications after liver transplantation. Clin Infect Dis, 2010; 51: e16-23
5. de Rooij BJ, van Hoek B, ten Hove WR et al: Lectin complement pathway gene profile of donor and recipient determine the risk of bacterial infections after orthotopic liver transplantation. Hepatology, 2010; 52: 1100-10
6. Vera A, Contreras F, Guevara F: Incidence and risk factors for infections after liver transplant: single-center experience at the University Hospital Fundación Santa Fe de Bogotá, Colombia. Transpl Infect Dis, 2011; 13: 608-15
7. Fishman JA: Infection in solid-organ transplant recipients. N Engl J Med, 2007; 357: 2601-14
8. Pungpapong S, Alvarez S, Hellinger WC et al: Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome. Liver Transpl, 2006; 12: 1244-52
9. Reid GE, Grim SA, Sankary H et al: Early intraabdominal infections associated with orthotopic liver transplantation. Transplantation, 2009; 87: 1706-11
10. Bert F, Larroque B, Paugam-Burtz C et al: Microbial epidemiology and outcome of bloodstream infections in liver transplant recipients: an analysis of 259 episodes. Liver Transpl, 2010; 16: 393-401
11. Saner FH, Olde Damink SW, Pavlakovic G et al: Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients. Transplantation, 2008; 85: 1564-68
12. Bellier C, Bert F, Durand F et al: Risk factors for Enterobacteriaceae bacteremia after liver transplantation. Transpl Int, 2008; 21: 755-63
13. García Prado ME, Matia EC, Ciuro FP et al: Surgical site infection in liver transplant recipients: impact of the type of perioperative prophylaxis. Transplantation, 2008; 85: 1849-54
14. Cerutti E, Stratta C, Romagnoli R et al: Bacterial-and fungal-positive cultures in organ donors: clinical impact in liver transplantation. Liver Transpl, 2006; 12: 1253-59
15. Mattner F, Kola A, Fischer S et al: Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation. Infection, 2008; 36: 207-12
16. Nery JR, Weppler D, Ketchum P et al: Donor infection and primary nonfunction in liver transplantation. Transplant Proc, 1997; 29: 481-83
17. Bud O, Golling M, von Frankenberg M et al: Intramucosal pH and serum endotoxin concentrations as early predictive parameters for primary nonfunction after experimental liver transplantation. Transplant Proc, 2000; 32: 2537-38
18. Ruiz P, Gastaca M, Gonzalez J et al: Incidence and clinical relevance of bacterial contamination in preservation solution for liver transplantation. Transplant Proc, 2009; 41: 2169-71
19. Janny S, Bert F, Dondero F et al: Microbiological findings of culture-positive preservation fluid in liver transplantation. Transpl Infect Dis, 2011; 13: 9-14
20. Chaim FH, Boin IF, Ataide EC, Stucchi RS: Perfusion fluid contamination in relation to recipient survival and acute cellular rejection in orthotopic liver transplantation: retrospective analysis. Transplant Proc, 2011; 43: 1313-15
21. Audet M, Piardi T, Panaro F et al: Incidence and clinical significance of bacterial and fungal contamination of the preservation solution in liver transplantation. Transpl Infect Dis, 2011; 13: 84-88
22. Sauget M, Verdy S, Slekovec C et al: Bacterial contamination of organ graft preservation solution and infection after transplantation. Transpl Infect Dis, 2011; 13: 331-34
23. Vandecasteele E, De Waele J, Vandijck D et al: Antimicrobial prophylaxis in liver transplant patients-a multicenter survey endorsed by the European Liver and Intestine Transplant Association. Transpl Int, 2010; 23: 182-90
24. Wood RP, Melendez T, Langnas AN et al: The viability of microorganisms in preservation solutions. Transplantation, 1991; 51: 239-42